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a b s t r a c t 
This paper presents the design of a modular point of care test platform that integrates a proprietary 
sample collection device directly with a microﬂuidic cartridge. Cell lysis, within the cartridge, is con- 
ducted using a chemical method and nucleic acid puriﬁcation is done on an activated cellulose mem- 
brane. The microﬂuidic device incorporates passive mixing of the lysis-binding buffers and sample using 
a serpentine channel. Results have shown extraction eﬃciencies for this new membrane of 69% and 57% 
compared to the commercial Qiagen extraction method of 85% and 59.4% for 0.1 ng/ μL and 100 ng/ μL 
salmon sperm DNA respectively spiked in phosphate buffered solution. Extraction experiments using the 
serpentine passive mixer cartridges incorporating lysis and nucleic acid puriﬁcation showed extraction 
eﬃciency around 80% of the commercial Qiagen kit. Isothermal ampliﬁcation was conducted using ther- 
mophillic helicase dependant ampliﬁcation and recombinase polymerase ampliﬁcation. A low cost bench- 
top real-time isothermal ampliﬁcation platform has been developed capable of running six ampliﬁcations 
simultaneously. Results show that the platform is capable of detecting 1.32 ×10 6 of sample DNA through 
thermophillic helicase dependant ampliﬁcation and 1 ×10 5 copy numbers Chlamydia trachomatis genomic 
DNA within 10 min through recombinase polymerase nucleic acid ampliﬁcation tests. 
© 2016 The Author(s). Published by Elsevier Ltd on behalf of IPEM. 

































The accurate and rapid identiﬁcation of pathogens is important
n global health to enable immediate and appropriate treatment
or vulnerable and hard to reach populations. This is particularly
rue for sexually transmitted infections (STIs) with the occurrence
f extremely drug resistant Neisseria Gonorrhoea [1] . Nucleic acid
mpliﬁcation testing (NAAT) has become increasingly used for
oint of care test (POCT) development due to its potential for
igh sensitivity and selectivity, but there is a challenge to provide
nexpensive, portable and mains-power independent platforms for
emote settings that allow for simple sample handling. Sample
ollection and integration with preparation methods including nu-
leic acid extraction has inhibited the uptake of commercial POCT
evices. A hand-held, battery operated, integrated microengineered∗ Corresponding author. Tel.: + 44 1895267378. 
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 http://creativecommons.org/licenses/by/4.0/ ) latform is under development for sample collection, automated
NA extraction, isothermal ampliﬁcation [2] and optical detection
irectly from raw samples such as urine, blood, swabs and saliva
 Fig. 1 a). Whilst a number of companies have developed point of
are devices, for example the Cepheid GeneXpert, Bioﬁre Filmarray
nd the LIAT analyser, all of the systems are benchtop, require
ains power and some hands on sample preparation [3-6] . The
ost of the benchtop devices tend to be high, within this paper
he development of a prototype, handheld, low cost ampliﬁcation
nd detection platform that cost less than GBP150 for parts and
abour is described. 
In addition to this, a simple, disposable sample collection device
 Fig. 1 b) that can be used to collect self-taken urine and swab sam-
les is also being developed. The sample collection device is de-
igned to interface directly with a disposable microﬂuidic cartridge
ia a Luer ﬁtting in which the assay is conducted. The sample will
e delivered into the cartridge through a plunging mechanism. This
evice and its corresponding interface mechanism are under de-
elopment and not described herein. The vision of the project isopen access article under the CC BY license. 






Fig. 1. Integrated micro-engineered platform: (a) sample-in-to-answer-out system 




































































o  that the prototype ampliﬁcation and detection platform described
herein will be developed into a handheld device ( Fig. 1 c) integrat-
ing the optics and heating elements along with data acquisition,
control and communications hardware. This handheld device will
automate sample analysis and send results directly to clinicians, via
a mobile phone, for rapid diagnosis to expedite time to treatment.
We aimed to initially target genital samples for the rapid diagnosis
of STIs. 
The POCT has been developed using a modular process ( Fig. 2 )
enabling any section to be removed and replaced by an alternative
method. For example, communications with the handheld device
could be achieved using the state-of-the-art wireless technologies
or USB depending on the setting in which the device is employed.
Similarly sample preparation, isothermal ampliﬁcation and detec-
tion types can be altered depending on the setting and disease
type that is being identiﬁed. 
Nucleic acid extraction for POCT devices is dominated by solid
phase extraction with chaotropic salts using silica membrane,
columns [7, 8] and magnetic beads [9] ; Drawbacks of these meth-
ods for POCT development include the required centrifugation for
membranes and an external magnetic ﬁeld for active mixing ofagnetic beads, whilst the use of toxic guanidinium thiocyanate
an inhibit downstream polymerase chain reaction (PCR) [10] . This
aper reports a method of DNA isolation using chitosan impreg-
ated on an organic membrane inserted into polydimethylsiloxane
PDMS)/glass prototyped microﬂuidic devices. Chitosan was chosen
s it simpliﬁes the extraction process and removes the require-
ent for guanidium thiocyanate. Chitosan is a deacetylated form
f chitin. Protonation of amine groups cause chitosan to exist as a
olycationic polymer at pH < 6.2, whereas at higher pH, the amine
roups are deprotonated. Protonation of the amine groups causes
he chitosan to be cationic, thus it adsorbs negatively charged DNA,
hen deprotonated (at higher pH) the DNA is released into the
urrounding solution [11, 12] . 
Polymerase chain reaction (PCR) was the ﬁrst method em-
loyed for nucleic acid ampliﬁcation testing (NAAT). More recently
sothermal ampliﬁcation methods have been developed that utilise
nzymes for DNA strand separation [1] . Isothermal methods were
hosen for this project as they remove the requirement for rapid
eating and cooling steps required in PCR, therefore less power is
onsumed within the handheld device. Optical detection of ampli-
ed DNA was chosen as this could be implemented in a low cost
anner in a handheld device using off the shelf components, and
llows real time visualisation of the NAAT reaction kinetics, the
eneﬁt of this over other methods is that the original sample load
an be determined [1] . Experiments were conducted using ther-
ophillic Helicase Dependent Ampliﬁcation (tHDA) and Recombi-
ase Polymerase Ampliﬁcation (RPA) to show the versatility of the
latform. 
The following sections describe the fabrication and assembly
f the prototype platform, design and optimisation of the heat-
ng module and optics. Further, the design of the microﬂuidic car-
ridge, on-chip DNA extraction and isothermal ampliﬁcation are
lso discussed. 
. Platform development 
A low cost isothermal ampliﬁcation and optical detection plat-
orm has been developed incorporating a resistive heating element,
ow cost photodiodes, LEDs and optical ﬁlters ( Figs. 3 and 4 ). The
ontrol and data acquisition was conducted using two Arduino Uno
icrocontroller boards. 
The platform was produced by assembling the layers of printed
ircuit boards (PCB) ( Fig. 4 a–d) with layers of laser cut PMMA
s support structures to produce a ﬁnal device with a height
f 32 mm, depth of 54 mm and length of 100 mm. This allows
his prototype design to be easily packaged within the envisioned
andheld device ( Fig. 1 c). 
.1. Heating element design 
A resistive heating element ( Fig. 4 d) was designed and devel-
ped from a two-layer printed circuit board using standard photo-
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Fig. 3. Small footprint, low cost, isothermal ampliﬁcation platform with two Arduino Uno microcontroller boards for thermal control and data acquisition. 
Fig. 4. Isothermal ampliﬁcation platform layers: (a, b) photodiode PCB bottom and top respectively; (c) black laser cut PMMA layer housing six long pass optical ﬁlters; 
(d) resistive heating element PCB with integrated thermistor; (e) the assembled device and aluminium plate for eﬃcient heat distribution across the microﬂuidic cartridge 




























T  tching methods. A surface mount thermistor was integrated cen-
rally on the heating element to monitor and control temperature
hanges in the heater. An aluminium plate was attached to this
eating element using a heat transfer adhesive as shown in Fig. 4 e,
o function as an isothermal plate to distribute the heat evenly to
he chip and thermistor. The heating element produced suﬃcient
nergy to reach the required temperatures; 65 °C to perform the
HDA and 37 °C to perform RPA isothermal NAAT in ≈90 s. 
.2. Optics 
A low-cost photodiode (BPW21, Centronic, UK) with a high gain
perational ampliﬁer (OPA4705, Texas Instruments, USA) with 1 G Ω
eedback resistor was utilised to perform the optical detection ( Fig.
 a and b). The photodiodes were coupled to the device via a
5 mm long section of hand polished, unjacketed 30 0 0 μm plasticptical ﬁbre (Edmund Optics, Barrington NJ, USA). A long pass ﬁlter
ut from orange glass (OG515, Schott AG, Germany) was placed be-
ween the photodiode and the optical ﬁbre ( Fig. 4 c). The optical ﬁ-
re was aligned through a hole on the heating element and on the
sothermal plate to rest ﬂush to the upper surface of the isother-
al plate where the underside of the microﬂuidic chambers come
o rest. A 3 mm LED (L-7104QBC-D, Kingbright, Taiwan) which illu-
inated the chip orthogonal to the optical ﬁbre was used to per-
orm the excitation at 470 nm ( Fig. 4 e). 
.3. Control and signal acquisition 
The control of the heating element and excitation LEDs, in ad-
ition to the acquisition and processing of sensor output, was per-
ormed using two Arduino Uno microcontroller boards (Arduino,
urin, Italy). One board was used to control the heating element


















































































































k  and the other was used to control the excitation LED and acquire
the photosensor data. Control of the heating element was per-
formed using a simple bang-bang control algorithm which trig-
gered in response to thermistor temperature on the heating ele-
ment. Separate software written in the Arduino environment was
used to initiate excitation LEDs and acquire 20 photosensor read-
ings over 300 ms and return an average of readings following a
pre-sampling delay to allow for sensor rise time. Fluorescence sig-
nal sampling from each chamber was performed in serial order to
prevent crosstalk between different reaction chambers. Data out-
put from the microcontroller, time stamp (seconds) and raw ﬂu-
orescence signal (0–50 0 0 mV), were recorded to study change in
ﬂuorescence of the reaction over time. Acquired real-time data was
displayed on a PC for analysis and downloaded and further pro-
cessed to produce Figs. 8 –10. 
3. Methodology 
3.1. Heating element optimisation 
The platform was set to 44 °C and switched on for 10 min to
ensure even heat distribution across the isothermal plate. Thermal
control was implemented using an Arduino Uno microcontroller
board. A 6 well, open test chip was ﬁlled with 50 μL of nuclease
free water. A digital thermometer and K-type thermocouple were
used to measure the temperature in each well, a jig was used to
ensure temperature measurements were made at the same height
in each ﬂuid ﬁlled well. 
3.2. Microﬂuidics 
The microﬂuidic cartridge was designed to allow the sample
to mix eﬃciently with the lysis binding buffer prior to the ex-
traction chamber. Due to the laminar nature of the ﬂow within
the microﬂuidic devices (Re < 1), passive mixing was utilised via
a serpentine channel. In order to do this, four cartridges of varying
design were fabricated and tested experimentally. The cartridges
incorporated a 0.5 × 0.5 mm 2 (width × height) serpentine channel
with or without a pre-mixing chamber. The pre-mixing chamber
incorporated geometries including a trapezoid, pear and ellipsoid
structures. 
Microﬂuidic moulds were designed using Solidworks CAD soft-
ware and saved as STL ﬁles. The moulds were created using 3D
printing techniques with an Objet 30 Pro using jetted photopoly-
mer deposition. QSil 218 PDMS (ACC Silicones, UK) was mixed at a
ratio of 1:10 for 2 min and then degassed using a centrifugal de-
gasser for 4 min. The moulds were cleaned by rinsing with iso-
propanol alcohol and then DI H 2 O to remove contaminants; they
were then dried using nitrogen. The mould was placed into a cus-
tom made stainless steel frame which was cleaned in the same
manner. After degassing the PDMS it is poured gently into the
mould and left in the oven at a set temperature of 45 °C for 4 h.
The cured PDMS was removed from the mould; a handheld corona
treater, BD20-AC (Electro-Technic Products Inc., US), was used to
bond the PDMS to a 75 ×50 mm 2 glass slide. The nucleic acid ex-
traction membrane was placed in the chamber and the treated sur-
faces are then pressed together and placed in an oven at 45 °C for
8 h. 
The microﬂuidic device incorporates sample and buffer inlets,
a pre-mixing chamber, passive serpentine mixer and nucleic acid
extraction membrane ( Fig. 5 ). 
3.3. DNA extraction 
Chitosan was dissolved in 2 v/v% acetic acid with varying
weight percentages of chitosan (1–5 w/v%). Various grades ofhatman chromatography paper were used as membranes, thus
 hybrid plastic paper microﬂuidic device was created. Mem-
ranes were added to the solution and cross-linked using ei-
her 1 v/v% glutaraldehyde (GA) or 0.1 v/v% (3-Glycidoxypropyl)
ethyldiethoxysilane (GPTMS). The membranes were left in so-
ution for eight hours, removed and thoroughly rinsed in 10 mM
cetic acid. Membranes were dried in an oven at 60 °C for one
our. The membranes were inserted into a microﬂuidic chamber
ith a total volume of 100 μL. 
Membranes were tested by spiking TE buffer with salmon
perm DNA with concentrations of 100 ng/ μL and 0.1 ng/ μL. Fur-
her tests were conducted incorporating lysis by purifying DNA
rom Escherichia coli ( E. coli ) spiked phosphate buffered solution
sing four designs of passive mixing-lysis-extraction cartridges
 Fig. 2 b). The buffers and sample were loaded into a length of
.5 mm tubing so that they could be ﬂowed in sequence into the
icroﬂuidic chamber. 2-(N-morpholino)ethanesulfonic acid (MES)
uffer (10 mM) was prepared at pH 5.0 (pH 3.0 if alkaline ly-
is was required). Samples were eluted using 10 mM TRIS buffer
t pH 9 and pH 9.5. A volume of 25 μL MES buffer was passed
ver the membrane at a ﬂow rate of 1.53 μL/s, this was left in
he chamber for 5 min to ensure protonated amino groups were
ormed on the chitosan surface. The sample (25 μL) was ﬂowed
irectly into the chamber with MES buffer solution; this was left
or 5 min. The solution was removed from the chamber by ﬂow-
ng air into the device at 3 μL/s. The elution buffer (50 μL) was
owed into the device at 1.53 μL/s and left for 10 min, this was
emoved and the extraction eﬃciency was calculated by measur-
ng the concentration of DNA that was eluted from the membrane.
his was compared with the original sample, measurements were
ade using a NanoDrop Spectrophotometer and Qubit HS dsDNA
ssay with a Qubit Fluorometer. Concurrent experiments were con-
ucted using a Qiagen mini prep commercial DNA extraction kit for
omparison. 
.4. DNA ampliﬁcation 
Separate microﬂuidic cartridges containing six individual cham-
ers ( Fig. 4 f) were designed and manufactured to test isothermal
AAT assays and real time optical detection. NAAT tests were con-
ucted using a one-step tHDA (BioHelix, US) and RPA technolo-
ies (TwistDx, UK). The tHDA reactions were performed using the
rimers and positive control provided with the tHDAIII kit. The
aster mix was prepared in ratios as described in the test man-
al [13] . Primers, MGF3 (forward) and NGR3 (reverse) were used
t a ﬁnal concentration of 7.5 nM each and 20 pg control template
CNG1 was added. Reagents were mixed and pipetted manually
nto the 6 well microﬂuidic device ( Fig. 4 f). The microﬂuidic car-
ridge was placed onto the pre-heated isothermal plate at 68 °C
nd data collection was initiated. 
An RPA assay (TwistAmp fpg) targeting the CDS2 gene of
hlamydia trachomatis (CT) was designed based on the primer set
nformation provided by [14] . A sequence speciﬁc probe for real
ime optical detection was designed as described in the test man-
al [15] . The sequences of the primer sets and probe are indicated
n Table 1 . The RPA reaction mix was made with 2.1 μL of each
f the forward and reverse primers and 1.2 μL of the probe with
oncentrations of 10 μM and 5 μM respectively in an Eppendorf
ube containing 29.5 μL of the rehydration buffer. 11.6 μL DNA free
ater was added to the reaction mix together with 1 μL of CT ge-
omic DNA (VR-348BD ۛC. trachomatis genomic DNA BOUR; Serovar
, LGC, UK) containing 1 ×10 5 copies to result in a ﬁnal volume of
7.5 μL. The reaction mix was used to rehydrate the freeze-dried
eaction through pipetting and was kept in ice to inhibit reaction
nitiation. Finally, 2.5 μl of the magnesium salt supplied with the
it was added to the reaction and mixed well through pipetting
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Fig. 5. Credit card sized microﬂuidic extraction cartridge incorporating a passive serpentine mixer. 
Table 1 
Chlamydia trachomatis speciﬁc ampliﬁcation primers and probe sequences used within the RPA isothermal ampliﬁcation assays. 
Primer/probe name Size (bp) Sequence (5 ʹ–3 ʹ) 
CDS2-FW (forward primer) 33 CCT TCA TTA TGT CGG AGT CTG AGC ACC CTA GGC 
CDS2-RV (reverse primer) 32 CTC TCA AGC AGG ACT ACA AGC TGC AAT CCC TT 
fpg Modiﬁed probe 33 [5 ʹBHQ1] GTT T[dR-FAM] T ACT CCG TCA CAG CGG TTG CTC GAA GCA [3 ʹ-block] 



















cnd manually loaded into the 6 well microﬂuidic cartridge. The
artridge was then placed onto the pre-heated (10 min) isothermal
late at 44 °C and data collection was initiated. 
. Results and discussion 
.1. Heating element 
The resistive heating element provided precise and stable heat-
ng of the microﬂuidic cartridge, a small thermal gradient across
he device was seen but this was less than 2 °C. Fig. 6 belowndicates the distance of the well from the centre of the heat-
ng plate and their corresponding chamber temperatures when the
esistive heater temperature was set to 44 °C; temperature mea-
urements were taken ﬁve times for each chamber which corre-
ponds to the error bars in Fig. 6 . Similar experiments carried out
o evaluate the platforms’ capability to provide heating to conduct
HDA ampliﬁcations demonstrated that the thermal gradient was
maller than 0.8 °C. The small thermal gradient did not show a
ariance in the ampliﬁcation time or gradient when the ampli-
cation performance was monitored in the central and outlying
hambers. 
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Fig. 7. (a) Extraction results for the new membrane compared to a Qiagen spin column extraction with varying concentrations of DNA; and (b) passive mixing device results 



























t4.2. DNA extraction 
Cross-linking chitosan using GA gave the highest extraction re-
sults. However, it was noted that cross-linking was uneven across
the surface of the membrane and large variation in the extrac-
tion eﬃciency was seen. The extraction eﬃciency was lower when
high DNA concentrations were used, at 100 ng/ μL both the Qiagen
and chitosan membranes showed lower extraction eﬃciencies, the
membrane may be saturated and unable to adsorb more DNA ( Fig.
7 a). 
Results for membranes tested on the benchtop, impregnated
with 4 w/v% chitosan and cross linked with GA showed extraction
eﬃciencies of 82% and 63% respectively for samples of 0.1 ng/ μL
and 100 ng/ μL. When the membranes were inserted into the mi-
croﬂuidic device the extraction eﬃciency was lowered to 69%nd 57%. These compare to Qiagen spin column results of 85%
nd 59.4% ( Fig. 7 a). GPTMS cross linking gave more homogenous
esults, extraction eﬃciencies up to 58% have been shown for
.1 ng/ μL using a 1 w/v% chitosan membrane. At higher w/v% chi-
osan when cross-linked with GPTMS, it was diﬃcult to reverse
he protonation of the amino groups and therefore, elute DNA
rom the membrane at pH 9.0, but when the elution buffer pH
as increased to pH 9.5 bound DNA was released. However, eﬃ-
iency was lowered to < 30%. Early experiments showed poor wet-
ing of the chitosan membrane when the MES buffer was intro-
uced, therefore Triton-X 100 was added to the MES protonation
uffer, this signiﬁcantly increased extraction eﬃciency from 35% to
4.6%. Extraction experiments using E. coli , incorporating chemical
ell lysis in the passive mixer cartridges showed results with the
otal extraction eﬃciency around 80% of the Qiagen kit ( Fig. 7 b). 
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Fig. 8. HDA ampliﬁcation curves from the isothermal ampliﬁcation platform, posi- 
tive and negative reactions for 20 pg pCNG. 
Fig. 9. RPA ampliﬁcation curves of CT genomic DNA. The CT positive wells con- 
tained 1 ×10 5 copy numbers of CT genomic DNA, RPA positive well contained the 
positive sample provided with the TwistAmp fpg kit and the negative control well 
contained all reagents apart from the CT genomic DNA and the blank well contained 
DNA free water. 








































































 .3. DNA ampliﬁcation 
Both isothermal (tHDA and RPA) NAATs performed as expected
nd were repeatable across the device. The tHDA assay was able to
etect 1.32 ×10 6 copies of pCNG1 template ( Fig. 8 ) and the RPA as-
ay was able to detect CT genomic DNA within 10 min of the initi-
tion of the reaction ( Fig. 9 ). The preliminary RPA assays contained
 ×10 5 copies of CT genomic DNA and currently further studies are
eing carried out to evaluate the platforms’ performance with low
opy numbers of DNA. Assays run on the developed ampliﬁcation
nd detection platform were run concurrently on an Axxin T16-ISO
latform that showed similar reaction kinetics for both tHDA and
PA assays, this is shown in Fig. 10 using RPA negative control, RPA
ositive control, 1 ×10 6 , 1 ×10 5 copies and of CT DNA. 
The results show that the prototype platform can emerge as a
latform for iNAAT diagnostic assays. Additionally, the modular na-
ure of this platform enables it to be utilised as an assay develop-
ent tool or a diagnostic tool. Provided the low cost to fabricate
he platform, and its suitability to be packaged within a handheldtandalone unit, it is anticipated that this platform will produce a
rue point-of-care diagnostic device for molecular diagnostics. The
imit of detection of the platform at present is substantially high;
owever, this can be considerably reduced by optimising the DNA
xtraction eﬃciency and ampliﬁcation assay. Further, based on the
esults, it is evident that a detectable signal can be produced from
 raw sample within 40 min of reaction initiation. 
. Conclusions 
The work presented here shows a low cost, rapid nucleic
cid extraction, isothermal ampliﬁcation and detection platform.
ucleic acid extraction showed similar results to the commercial
xtraction kits, work is on-going to further optimise the results
sing clinical samples. This nucleic acid extraction method does
resent an advantageous solution, extraction time is reduced to
ess than 20 min and is extremely low cost, and this can also be an
dvantageous method for those working in the paper microﬂuidic
eld. The isothermal ampliﬁcation platform and resistive heating
lement proved a robust method to amplify nucleic acid using
sothermal assays and has shown repeatable results. The simple
ptics setup demonstrated high sensitivity and quick detection
f the tHDA and RPA reactions eliminating the requirement for
xpensive dichroic ﬁlters and lenses. The group is now developing
 new microﬂuidic cartridge with integrated nucleic acid extrac-
ion, which ﬁts into the current low cost isothermal ampliﬁcation
latform. This will have the ability to prove the sample-in-to-
nswer-out capability of the platform. The platform will be further
eveloped to create a robust handheld device with disposable
icroﬂuidic cartridges and simple, easy to use, sample collection
t much lower cost than comparable systems creating a versatile
ortable test for STIs. 
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